503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
18.54%
Revenue growth 1.25-1.5x ZETA's 16.65%. Bruce Berkowitz would examine if growth advantage is sustainable.
No Data
No Data available this quarter, please select a different quarter.
18.54%
Gross profit growth exceeding 1.5x ZETA's 8.15%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
18.54%
EBITDA growth below 50% of ZETA's 406.86%. Michael Burry would check for structural issues.
No Data
No Data available this quarter, please select a different quarter.
18.54%
Operating income growth below 50% of ZETA's 68.32%. Michael Burry would check for structural issues.
No Data
No Data available this quarter, please select a different quarter.
-18.54%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.10%
Share count reduction while ZETA shows 2.21% change. Joel Greenblatt would examine strategy.
-0.10%
Diluted share reduction while ZETA shows 2.21% change. Joel Greenblatt would examine strategy.